Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.

about

Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.

Item

http://www.wikidata.org/entity/Q45974877

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pharmacological and Non-pharma ...... ents with Atrial Fibrillation.

@en

Pharmacological and Non-pharma ...... ents with Atrial Fibrillation.

@nl

type

Item

label

Pharmacological and Non-pharma ...... ents with Atrial Fibrillation.

@en

Pharmacological and Non-pharma ...... ents with Atrial Fibrillation.

@nl

prefLabel

Pharmacological and Non-pharma ...... ents with Atrial Fibrillation.

@en

Pharmacological and Non-pharma ...... ents with Atrial Fibrillation.

@nl

P1476

Pharmacological and Non-pharma ...... ents with Atrial Fibrillation.

@en

P2093

Andreas Bollmann

http://www.w3.org/2001/XMLSchema#string

Laura Ueberham

http://www.w3.org/2001/XMLSchema#string

Tatjana S Potpara

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences

Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target

Percutaneous left atrial appendage closure: procedural techniques and outcomes

Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis

Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation

Dabigatran versus warfarin in patients with atrial fibrillation

Idarucizumab for Dabigatran Reversal

Direct thrombin inhibitors

Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol

P2888

s12325-017-0616-6

P304

2274-2294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S12325-017-0616-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gerhard Hindricks

Nikolaos Dagres

P577

2017-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091972607

http://www.w3.org/2001/XMLSchema#string

P698

28956288

http://www.w3.org/2001/XMLSchema#string

P921

AVC

Farmakologi

cerebrovascular disease

atrial fibrillation

P932

5656712

http://www.w3.org/2001/XMLSchema#string